Entrada Therapeutics Statistics
Total Valuation
TRDA has a market cap or net worth of $650.75 million. The enterprise value is $246.79 million.
Important Dates
The last earnings date was Tuesday, November 5, 2024, before market open.
Earnings Date | Nov 5, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
TRDA has 35.41 million shares outstanding. The number of shares has increased by 9.14% in one year.
Current Share Class | 35.41M |
Shares Outstanding | 35.41M |
Shares Change (YoY) | +9.14% |
Shares Change (QoQ) | +14.43% |
Owned by Insiders (%) | 1.45% |
Owned by Institutions (%) | 51.80% |
Float | 18.45M |
Valuation Ratios
The trailing PE ratio is 11.64.
PE Ratio | 11.64 |
Forward PE | n/a |
PS Ratio | 2.95 |
Forward PS | 11.18 |
PB Ratio | 1.50 |
P/TBV Ratio | 1.50 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | 4.49 |
EV / Sales | 1.15 |
EV / EBITDA | 4.03 |
EV / EBIT | 4.27 |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.59, with a Debt / Equity ratio of 0.15.
Current Ratio | 6.59 |
Quick Ratio | 6.42 |
Debt / Equity | 0.15 |
Debt / EBITDA | 0.81 |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 16.43% and return on invested capital (ROIC) is 9.03%.
Return on Equity (ROE) | 16.43% |
Return on Assets (ROA) | 6.95% |
Return on Capital (ROIC) | 9.03% |
Revenue Per Employee | $1.35M |
Profits Per Employee | $345,604 |
Employee Count | 159 |
Asset Turnover | 0.41 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, TRDA has paid $21.47 million in taxes.
Income Tax | 21.47M |
Effective Tax Rate | 28.09% |
Stock Price Statistics
The stock price has increased by +12.39% in the last 52 weeks. The beta is -0.27, so TRDA's price volatility has been lower than the market average.
Beta (5Y) | -0.27 |
52-Week Price Change | +12.39% |
50-Day Moving Average | 17.00 |
200-Day Moving Average | 15.21 |
Relative Strength Index (RSI) | 53.49 |
Average Volume (20 Days) | 132,641 |
Short Selling Information
The latest short interest is 1.66 million, so 4.70% of the outstanding shares have been sold short.
Short Interest | 1.66M |
Short Previous Month | 1.65M |
Short % of Shares Out | 4.70% |
Short % of Float | 9.02% |
Short Ratio (days to cover) | 15.27 |
Income Statement
In the last 12 months, TRDA had revenue of $215.23 million and earned $54.95 million in profits. Earnings per share was $1.55.
Revenue | 215.23M |
Gross Profit | 95.04M |
Operating Income | 57.78M |
Pretax Income | 40.51M |
Net Income | 54.95M |
EBITDA | 61.30M |
EBIT | 57.78M |
Earnings Per Share (EPS) | $1.55 |
Full Income Statement Balance Sheet
The company has $449.34 million in cash and $61.31 million in debt, giving a net cash position of $388.03 million or $10.96 per share.
Cash & Cash Equivalents | 449.34M |
Total Debt | 61.31M |
Net Cash | 388.03M |
Net Cash Per Share | $10.96 |
Equity (Book Value) | 422.45M |
Book Value Per Share | 11.93 |
Working Capital | 394.73M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$13.97 million and capital expenditures -$3.50 million, giving a free cash flow of -$17.46 million.
Operating Cash Flow | -13.97M |
Capital Expenditures | -3.50M |
Free Cash Flow | -17.46M |
FCF Per Share | -$0.49 |
Full Cash Flow Statement Margins
Gross margin is 44.16%, with operating and profit margins of 26.85% and 25.53%.
Gross Margin | 44.16% |
Operating Margin | 26.85% |
Pretax Margin | 35.51% |
Profit Margin | 25.53% |
EBITDA Margin | 28.48% |
EBIT Margin | 26.85% |
FCF Margin | -57.65% |
Dividends & Yields
TRDA does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -9.14% |
Shareholder Yield | -9.14% |
Earnings Yield | 8.66% |
FCF Yield | -2.75% |
Analyst Forecast
The average price target for TRDA is $23.33, which is 26.93% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $23.33 |
Price Target Difference | 26.93% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | 19.23% |
EPS Growth Forecast (5Y) | n/a |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
TRDA has an Altman Z-Score of 3.5 and a Piotroski F-Score of 5.
Altman Z-Score | 3.5 |
Piotroski F-Score | 5 |